Anita Lövgren‐Sandblom

1.7k total citations
33 papers, 1.2k citations indexed

About

Anita Lövgren‐Sandblom is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Anita Lövgren‐Sandblom has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 18 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Anita Lövgren‐Sandblom's work include Cholesterol and Lipid Metabolism (20 papers), Drug Transport and Resistance Mechanisms (14 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Anita Lövgren‐Sandblom is often cited by papers focused on Cholesterol and Lipid Metabolism (20 papers), Drug Transport and Resistance Mechanisms (14 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Anita Lövgren‐Sandblom collaborates with scholars based in Sweden, United States and United Kingdom. Anita Lövgren‐Sandblom's co-authors include Ingemar Björkhem, Jure Ačimovič, Lena Starck, Hanns–Ulrich Marschall, Ulf Diczfalusy, Catherine Williamson, Maria Olin, Marjan Shafaati, Peter A. Edwards and Damjana Rozman and has published in prestigious journals such as PLoS ONE, Hepatology and Biochemical and Biophysical Research Communications.

In The Last Decade

Anita Lövgren‐Sandblom

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anita Lövgren‐Sandblom Sweden 21 752 482 448 119 118 33 1.2k
Sundararajah Thevananther United States 26 707 0.9× 739 1.5× 795 1.8× 30 0.3× 85 0.7× 45 2.0k
Patrick Linsel‐Nitschke Germany 17 887 1.2× 755 1.6× 454 1.0× 26 0.2× 257 2.2× 24 1.7k
J. Gordon Porter United States 6 553 0.7× 510 1.1× 380 0.8× 23 0.2× 124 1.1× 6 1.0k
Kjell Torgeir Stokke Norway 14 586 0.8× 356 0.7× 171 0.4× 73 0.6× 276 2.3× 29 1.2k
Saime Aksoy United States 10 318 0.4× 480 1.0× 264 0.6× 26 0.2× 39 0.3× 12 1.0k
Run Lu United States 18 106 0.1× 470 1.0× 636 1.4× 91 0.8× 59 0.5× 26 1.5k
Hidenori Kawashima Japan 23 176 0.2× 426 0.9× 257 0.6× 32 0.3× 118 1.0× 59 1.1k
Alexandra G. Ianculescu United States 10 242 0.3× 864 1.8× 443 1.0× 26 0.2× 320 2.7× 10 1.4k
Nobuo Sekine Japan 15 440 0.6× 488 1.0× 186 0.4× 24 0.2× 298 2.5× 19 1.0k
Illiana Meurs Netherlands 21 911 1.2× 601 1.2× 374 0.8× 20 0.2× 321 2.7× 31 1.6k

Countries citing papers authored by Anita Lövgren‐Sandblom

Since Specialization
Citations

This map shows the geographic impact of Anita Lövgren‐Sandblom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita Lövgren‐Sandblom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita Lövgren‐Sandblom more than expected).

Fields of papers citing papers by Anita Lövgren‐Sandblom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita Lövgren‐Sandblom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita Lövgren‐Sandblom. The network helps show where Anita Lövgren‐Sandblom may publish in the future.

Co-authorship network of co-authors of Anita Lövgren‐Sandblom

This figure shows the co-authorship network connecting the top 25 collaborators of Anita Lövgren‐Sandblom. A scholar is included among the top collaborators of Anita Lövgren‐Sandblom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anita Lövgren‐Sandblom. Anita Lövgren‐Sandblom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matallana, C. de Paco, José Eliseo Blanco‐Carnero, Maudrian Burton, et al.. (2025). Randomized controlled trial of the impact of ursodeoxycholic acid on glycemia in gestational diabetes mellitus: the GUARDS trial. American Journal of Obstetrics & Gynecology MFM. 7(9). 101732–101732.
2.
Lövgren‐Sandblom, Anita, Nithya Sukumar, Yonas Ghebremichael‐Weldeselassie, et al.. (2024). Serum bile acid measurements in women of European and South Asian ethnicity with or without gestational diabetes mellitus: A cohort study. BJOG An International Journal of Obstetrics & Gynaecology. 131(9). 1218–1228. 1 indexed citations
3.
Schneider, Kai Markus, Annika Bergquist, Antonio Molinaro, et al.. (2022). Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis. JHEP Reports. 4(11). 100561–100561. 15 indexed citations
4.
Ovadia, Caroline, Anita Lövgren‐Sandblom, Jennifer Chambers, et al.. (2019). Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study. BJOG An International Journal of Obstetrics & Gynaecology. 126(13). 1633–1640. 33 indexed citations
5.
Ovadia, Caroline, Shadi Abu‐Hayyeh, Peter Dixon, et al.. (2014). P379 BIOCHEMICAL MARKERS FOR INTRAHEPATIC CHOLESTASIS OF PREGNANCY AND PRURITUS GRAVIDARUM IN WOMEN WITH GESTATIONAL PRURITUS. Journal of Hepatology. 60(1). S194–S194. 2 indexed citations
6.
Wuolikainen, Anna, Jure Ačimovič, Anita Lövgren‐Sandblom, et al.. (2014). Cholesterol, Oxysterol, Triglyceride, and Coenzyme Q Homeostasis in ALS. Evidence against the Hypothesis That Elevated 27-Hydroxycholesterol Is a Pathogenic Factor. PLoS ONE. 9(11). e113619–e113619. 38 indexed citations
7.
Heverin, Maura, Maria Olin, Jure Ačimovič, et al.. (2013). On the regulatory role of side-chain hydroxylated oxysterols in the brain. Lessons from CYP27A1 transgenic and Cyp27a1−/− mice. Journal of Lipid Research. 54(4). 1033–1043. 48 indexed citations
8.
Saeed, Ahmed, Jan Andersson, Irina A. Pikuleva, et al.. (2013). 7α-hydroxy-3-oxo-4-cholestenoic acid in cerebrospinal fluid reflects the integrity of the blood-brain barrier. Journal of Lipid Research. 55(2). 313–318. 38 indexed citations
9.
Björkhem, Ingemar, Anita Lövgren‐Sandblom, Valerio Leoni, et al.. (2013). Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. Neuroscience Letters. 555. 102–105. 93 indexed citations
10.
Abu‐Hayyeh, Shadi, Georgia Papacleovoulou, Anita Lövgren‐Sandblom, et al.. (2012). Intrahepatic Cholestasis of Pregnancy Levels of Sulfated Progesterone Metabolites Inhibit Farnesoid X Receptor Resulting in a Cholestatic Phenotype. Hepatology. 57(2). 716–726. 136 indexed citations
11.
Ačimovič, Jure, Anita Lövgren‐Sandblom, Lennart C. Eriksson, & Linda Björkhem‐Bergman. (2012). The anti-carcinogenic effect of statins in a rat model correlates with levels and synthesis of ubiquinone. Biochemical and Biophysical Research Communications. 425(2). 348–352. 9 indexed citations
12.
Nylén, Hanna, et al.. (2012). A comparison of 4β‐hydroxycholesterol : cholesterol and 6β‐hydroxycortisol : cortisol as markers of CYP3A4 induction. British Journal of Clinical Pharmacology. 75(6). 1536–1540. 40 indexed citations
13.
Shafaati, Marjan, Amelia Marutle, Hanna Pettersson, et al.. (2011). Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation. Journal of Lipid Research. 52(5). 1004–1010. 79 indexed citations
14.
Milagre, Inês, Maria Olin, Maria João Nunes, et al.. (2011). Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells. Neurochemistry International. 60(2). 192–198. 7 indexed citations
15.
Mast, Natalia, Marjan Shafaati, Wenchao Zheng, et al.. (2010). Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1801(6). 674–681. 22 indexed citations
16.
Ačimovič, Jure, Anita Lövgren‐Sandblom, Katalin Monostory, et al.. (2009). Combined gas chromatographic/mass spectrometric analysis of cholesterol precursors and plant sterols in cultured cells. Journal of Chromatography B. 877(22). 2081–2086. 71 indexed citations
17.
Tarr, Paul T., Greg D. Gale, Desmond Smith, et al.. (2009). Differential expression and function of ABCG1 and ABCG4 during development and aging. Journal of Lipid Research. 51(1). 169–181. 65 indexed citations
18.
Lövgren‐Sandblom, Anita, Maura Heverin, Hanna Larsson, et al.. (2007). Novel LC–MS/MS method for assay of 7α-hydroxy-4-cholesten-3-one in human plasma. Journal of Chromatography B. 856(1-2). 15–19. 34 indexed citations
19.
Starck, Lena, Anita Lövgren‐Sandblom, & Ingemar Björkhem. (2002). Simvastatin treatment in the SLO syndrome: A safe approach?. American Journal of Medical Genetics. 113(2). 183–189. 34 indexed citations
20.
Starck, Lena, Anita Lövgren‐Sandblom, & Ingemar Björkhem. (2002). Cholesterol treatment forever? The first Scandinavian trial of cholesterol supplementation in the cholesterol‐synthesis defect Smith–Lemli–Opitz syndrome. Journal of Internal Medicine. 252(4). 314–321. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026